Single-Dose, Randomized, Open-Label, Two-Way, Crossover Bioequivalence Study of Two Formulations of Pregabalin 300 mg Hard Capsules in Healthy Volunteers Under Fasting Conditions

Augusto Filipe,S. M. Almeida,Pedro Pedroso,Rita Neves,Susana Marques,Eric Sicard,Julie Massicotte,Jordi Ortuño

Single-Dose, Randomized, Open-Label, Two-Way, Crossover Bioequivalence Study of Two Formulations of Pregabalin 300 mg Hard Capsules in Healthy Volunteers Under Fasting Conditions

2015

Augusto Filipe
S. M. Almeida
Pedro Pedroso
Rita Neves
Susana Marques
Eric Sicard
Julie Massicotte
Jordi Ortuño

Aims This bioequivalence study was conducted to assess the bioequivalence of two formulations, test and reference, of pregabalin 300 mg hard capsules, under fasting conditions.

Keywords:

Diabetes mellitus
Crossover study
Body mass index
Bioequivalence
Medicine
Pharmacology
Pregabalin
Therapeutic equivalency
open label
bioequivalence study
Anesthesia
healthy volunteers
area under curve

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations